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Abstract
Background: Tuberculosis and sarcoidosis are chronic diseases that rarely occur concomitantly. Sarcoidosis is a
multisystem granulomatous disorder characterized pathologically by the presence of non-caseating granulomas in
involved tissues. Tuberculosis is infectious disease caused by Mycobacterium tuberculosis characterized by
granulomas with caseous necrosis.
Case presentation: We present a case of 43-year-old female refugee from Kosovo with microbiological
confirmation of pulmonary tuberculosis and pulmonary and skin sarcoidosis at the same time. Three weeks after
corticosteroid therapy for pulmonary sarcoidosis was introduced, positive finding of mycobacterium culture of
bronchial aspirate was observed. Based on these results, corticosteroid therapy was excluded and antituberculous
therapy was introduced for six months. In the meantime, new nodes on face and nose appeared and skin
sarcoidosis was diagnosed. The patient was given corticosteroids and colchicine according to the skin and
pulmonary sarcoidosis therapy recommendation.
Conclusion: The authors of this study suggest that in cases when there is a dilemma in diagnosis between
tuberculosis and sarcoidosis we should advance with corticosteroid therapy until we have microbiological
confirmation of mycobacterium culture. This case is remarkable because this is a third described case of sarcoidosis
and tuberculosis together (the first reported in Asia, the second in South Africa), and to authors knowledge, this is
a first case report in Europe.
Background
Tuberculosis and sarcoidosis are chronic granulomatous
diseases. In many aspects, they are similar although dif-
ferent. Tuberculosis is infectious disease caused by
Mycobacterium tuberculosis (MTB) characterized by
granulomas with caseous necrosis, and the treatment is
focused on elimination of microorganism. Sarcoidosis is
systemic disease of unknown etiology, and is character-
ized by noncaseous granulomas, therefore it cannot be
treated etiologically but immunosuppressive as a sys-
temic immunological disease [1,2]. Overall mortality
from sarcoidosis is 1-5% usually from respiratory, car-
diac or central nervous system disease [3]. The histolo-
gical similarity between sarcoidosis and tuberculosis
(with epithelioid cell granulomas as the typical common
finding) has stimulated the search for an association
between mycobacterium and sarcoidosis, and it has been
hypothesized that sarcoidosis could be a separate mani-
festation of infection with mycobacterium [2]. These dis-
eases occur concomitantly very rarely [4,5]. Less
commonly, tuberculosis develops as an opportunistic
infection in patients following corticosteroid treatment
for sarcoidosis.
Case presentation
In this very rare case of 43 years-old female, refugee
from Kosovo, was admitted as an outpatient to the
Department of pulmonary diseases in 2003. because of
erythema nodosum and dry cough. She was without
fever during admission, smoked up to 30 cigarettes daily
and was healthy most of her life. She suffered only of
head injury and face trauma acquired during the war
(during 1995.) by shelling. Three years before the
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neous tubercles were found on her forehead, in the left
eyebrow area. The biopsy test showed chronic granulo-
matous infection that was described as a reaction to a
foreign body.
Laboratory analysis revealed ESR 37 (normal range 0-
15 mm/h), WBC 9.030/mm
3, RBC 3,7/mm
3 and C-reac-
tive protein 9.8 mg/L, AST 60 U/L, ALT 76 U/L, GGT
86 U/L, AP 79 U/L, while urea, creatinine, calcium in
serum and 24 hours urine were within normal range.
Angiotensin-converting enzyme (ACE) was elevated 108
U/l (normal 0-56). Tuberculosis test (2 IU) was 14 mm
of induration in diameter. The result of spirometry mea-
sured 85% vital capacity (VC), 94,5% of forced vital
capacity (FCV), 77% of forced expiratory volume
(FEV),82,4% of forced expiratory volume in first second
(FEV1) and FEV1/FCV 87,2% from referral values. Arter-
ial blood gases were pO2 9,8 kPa, pH 7.45 and diffusing
capacity of carbon monoxide (DLCO) 72%. Chest radio-
gram showed fibroindurative changes in the area of
both upper lobes with lung traction. In upper lobes sub-
pleurally and more to the left there was a focus with
«round glass» pattern. Mycronodular interstitial infiltra-
tions were found bilateral on chest radiogram with
fibrous changes of hilus (Figure 1). High-resolution
computed tomography (HRCT) of thorax showed inter-
lobar and peribronchial thickness in upper lung lobes
with subpleural fibroses and deformation of bronchi.
There were minor areas of fresh infiltrations in apices
on both sides, suggesting a new pathological process.
There was a cavity 8 × 12 mm large in apical-posterior
segment of the upper left lobe. Hilar lymph nodes were
more then 2 cm in diameter, some of them had fibrous
changes and some were calcificated. High resolution
thorax CT with hilar lymph nodes enlargement and
granulomas with reticular interstitial pattern in the
lower respiratory part is present on the Figure 2(a, b).
Fiberbronchoscopy revealed slightly edematous and
hyperemic mucous membrane of bronchi on both sides,
while purulent secrete was seen in bronchus left upper
lobe and in lingul. The routine bacteriological culture of
bronchial aspirate was sterile. Direct smear microscopy
examination of the sample for the presence of acid-
resistant bacilli by using Ziehl-Neelsen method was
negative. Pathohistological findings of lung (Figure 3)
and bronchial walls biopsy showed chronic granuloma-
tous infection without caseous necroses. In bronchoal-
veolar lavage (BAL) CD4+ lymphocytes and alveolar
macrophages were predominantly. The ratio of CD4+
and CD8+ lymphocytes was 5.5:1. All relative findings,
including pathohistological examination indicate lung
sarcoidosis. The patient was stared corticosteroid ther-
apy (out of hospital-out-hospital patient) according to
usual scheme for lung sarcoidosis, prednisolone 1 mg/kg
body weight. Three weeks after introducing corticoster-
oid therapy, culturing the sample on Lowenstein-Jensen
solid medium by using liquid culture method MGIT
(Mycobacterium Growth Indicator Tube), Mycobacter-
ium tuberculosis was isolated. The sensitivity test was
performed by using the proportion method on solid
Lowenstein-Jansen culture according to CLSI (Clinical
and Laboratory Standards Institute) standards. All the
four routine tested antituberculotics (isoniazid, rifampi-
cin, ethambutol and streptomycin) responded well to
sensitivity test and the susceptibility of pyrasinamide
was confirmed in the referral national laboratory. A pre-
vious diagnosis was corrected to microbiological con-
firmed lung tuberculosis. Corticosteroid therapy was
excluded after three weeks of treatment and antituber-
culotic therapy (ATL) was introduced. The patient was
treated with rifampicin 600 mg, isoniazid 400 mg, etam-
buthol 1200 mg and pyrazinamide 1500 mg, on a daily
basis during two months, after pyrazinamide was
excluded and triple therapy was continued for one
month. After three months from the beginning of ATL
treatment, ethambuthol was excluded and rifampicin
and isoniazid were continued for the next 3,5 months
(entirely 6,5 months) with controlling regular hematolo-
gical and biochemical analysis. The patient was in good
clinical condition. However, ACE was continuously
raised, 80-100 U/l. After four months of ATL therapy
chest radiogram was made showing complete regression
of tiny infiltrates in both upper lobes and small regres-
sion of nodular infiltrates which was described as unsa-
tisfactory. During ATL therapy new nodes on face and
nose, similar to those on the forehead appeared (Figure
4). The biopsy of skin changes was made and the patho-
histological confirmation for sarcoidosis is evident on
t h eF i g u r e5 .A n t i t u b e r c u l o t i ct h e r a p yw a sp r e c e d e df o r
next two months until negative mycobacterium culture
in new collected sputum was obtained. In course of the
last month of TB therapy novel bigger, firm nodes
appeared on ear lap. Pathohistological tests indicate sar-
coidosis of the skin.
Microbiological examinations of the skin substrata in
direct microscopy and polymerase chain reaction (PCR)
with specific primer had not confirmed presence of M.
tuberculosis. After 6 months of the beginning of ATL
treatment, the patient received corticosteroid (predniso-
lone 40 mg daily) and colchicine therapy (200 mg daily)
for lung and skin type of sarcoidosis. After four months
of the corticosteroid therapy chest radiogram showed
almost complete regression of nodular infiltrates in lung
parenchyma. The skin changes were considerably smal-
ler, dry on surface, and there were no new lesions on
the skin while ACE was in normal rate (30 U/l).
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A rare case of skin and lung sarcoidosis with positive
mycobacterium culture obtained from bronchial aspirate
has been presented. Sarcoidosis is a common multisys-
tem granulomatous disease that frequently involves the
lungs and can result in pulmonary fibrosis [2]. Based on
positive finding of the bronchial aspirate, the diagnosis
of lung TB was confirmed. According to authors’ knowl-
edge there has not been described a case with positive
culture on MTB obtained from bronchial aspirate and
with noncaseous granulomas in lung parenchyma, bron-
chial wall and skin. Pathohistological findings of lung
and bronchial wall suggested on sarcoidosis, but confus-
ing fact was positive tuberculosis skin test, although it
can be positive in the cases of sarcoidosis. Recent inno-
vative blood tests that measure the cell-mediated
immune response of TB-infected individuals like quanti-
feron test are highly specific for detecting M. tuberculo-
sis infection and may be helpful in diagnostic
evaluations in conjuction with risk assessment and
radiography [6]. At the time of patient admission, we
did not use quantiferon-TB Gold test yet.
In the last 20 years, the research papers have
recorded detection of mycobacterial DNA in some
sarcoide lesions, especially in lymph nodes that indi-
cates possible connection between these two diseases
[7-11]. Silent asymptomatic stage I of sarcoidosis
complicated with pulmonary tuberculosis has been
recent published [12].
Figure 1 Chest radiogram with fibroproductive changes in the
area of both upper lobes and mycronodular interstitial
infiltration bilateral.
Figure 2 Thorax CT with hilar lymph nodes enlargement (a) and reticular interstitial pattern with granulomas of both lower lobus (b).
Figure 3 Pathohistological findings of lung and bronchial walls
biopsy showed chronic granuloma infection without caseotin
necrosis, characteristic for sarcoidosis.
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toms. Noncaseating epitheloid cell granulomas charac-
terizing sarcoidosis may affect most organs, including
the skin. Skin lesions may be the only manifestations, or
just one of several other organ involvements. Cutaneous
lesions are present in ~25% of sarcoidosis patients [13].
The skin lesions could have specific aspects (papules,
plaques, nodules, alopecia or purple scars) or can be
more or less nonspecific (erythema nodosum) [14]. In
the Netherlands epidemiological study sarcoidosis was
mostly associated with rheumatoid arthritis [15].
The presented case has been of clinical interest
because it happens very rarely that pulmonary tubercu-
losis and lung sarcoidosis coincide in the same patient
with noncaseous lung granulomas. The dilemma was
present only because Mantoux test (skin test) was posi-
tive. In the former states of Yugoslavia tuberculosis skin
test was positive in more than 95% of population
because bacillus Calmette-Guerin vaccination (BCG vac-
cine) was compulsory. It had to be carried out just after
birth and then three times until a person was 18 years
old. In spite of vaccination, inhabitants can come in
touch with the infected persons, and it happened more
often during the war in Croatia (1991.-1995.) and
another parts of former Yugoslavia, because of the
migration of the population from other parts of the Bal-
kan (refugees, fugitives from Bosnia and Kosovo) where
the incidence of lung tuberculosis was very high, com-
paring to Croatia (Kosovo 80/100000, Southern Croatia
18-20/100 000).
In the Sothern Croatia ratio of tuberculosis and sar-
coidosis is 1:10 [16]. During ATL therapy complete
regressions of new infiltrates in the upper lobe without
mycronodular infiltrates has been achieved. Skin sarcoi-
dosis was pathohistological confirmed, with negative
direct smear microscopy examination in Ziehl-Neelsen
stain and absence of mycobacterium DNA in skin
granulomas.
Absence of mycronodular infiltrates (granulomas) in
lung parenchyma and reduced changes of skin during 4
months of corticosteroid therapy have additionally
proved the diagnosis of sarcoidosis with M. tuberculosis
positive lung tuberculosis. Three years before sarciodosis
and tuberculosis had been diagnosed, skin forehead
granuloma was verified which was explained as granu-
loma of a foreign body due to previous injuries at shel-
ling. However, according to this study, skin sarcoidosis
cannot be excluded at that time. If the bronchial aspi-
rate had not been sent for microbiological testing and if
the therapy with corticosteroid had continued, a severe
type of lung TB with cavities and probably galloping
tuberculosis would have been developed. This particular
represented case suggests us if suspicion of tuberculosis
is high (for example when the patient had a tuberculin
test of 14 mm, a cavity 8 × 12 mm in the apical-poster-
ior segment of the upper left lobe and purulent secre-
tion from the left upper lobe bronchus on
bronchoscopy) the ATL treatment can start
Figure 4 Multiple new nodes on face during ATL therapy
pathohistological verified as sarcoide granulomas.
Figure 5 Pathohistological evidence of noncaseating
granulomas in skin biopsy, characteristic for sarcoidosis.
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rapidly deteriorating, corticosteroids and antituberculo-
sis therapy could be started concurrently, until micro-
biological confirmation is established.
In cases when there is a dilemma in diagnosis between
tuberculosis and sarcoidosis, we should advance with
corticosteroid therapy until we have microbiological
confirmation of mycobacterium culture [17]. In this par-
ticular case the doubt has been present from the very
beginning, because of the positive skin test and data of
previous living place where the incidence of tuberculosis
is still high.
Conclusion
We have presented the case of a patient with microbio-
logical confirmation of pulmonary tuberculosis and pul-
monary and skin sarcoidosis at the same time and have
emphasized the diagnostic dilemmas that may occur
when these conditions coexist. The beginning of steroid
therapy in patients with underlying infection may
accentuate life-threatening complications. The proper
evaluation of all relevant findings and case-history data
needs to be considered. The authors suggest that in
cases when there is a dilemma in diagnosis between
tuberculosis and sarcoidosis we should advance with
corticosteroid therapy until we have microbiological
confirmation of mycobacterium culture.
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